Ketoconazole treatment in superficial mycoses
- PMID: 3720525
Ketoconazole treatment in superficial mycoses
Abstract
Ketoconazole is a new antifungal drug, used for oral treatment, with a broad spectrum of activity. It is a member of the imidazole series and is active in superficial and deep mycotic diseases, in candidosis and pityriasis versicolor. This new imidazole derivative has been successfully administered in several cases of dermatophytosis, yeasts and pityriasis versicolor in the authors' clinic, as well as in many other research centres. Treatment has been given to patients with tinea corporis, tinea cruris, tinea pedis, with or without location in interdigital spaces, while the cases of tinea capitis are still under investigation. The following variants of candida infections have been treated: onychomycosis, intertrigo and mucocutaneous candidosis due to prolonged immunosuppressive therapy. No remarkable haematochemical disorders have been observed after treatment.
Similar articles
-
Ketoconazole: therapeutic results obtained in the district of Cagliari.Drugs Exp Clin Res. 1986;12(5):415-8. Drugs Exp Clin Res. 1986. PMID: 3522161 Clinical Trial.
-
[Superficial mycoses in immunosuppressed patients].Rev Clin Esp. 1995 Oct;195 Suppl 3:49-55. Rev Clin Esp. 1995. PMID: 9441306 Review. Spanish. No abstract available.
-
[Clotrimazol therapy of skin mycoses].Hautarzt. 1977 Mar;28(3):140-4. Hautarzt. 1977. PMID: 323196 Clinical Trial. German.
-
A clinical and mycological assessment of tioconazole solution in the treatment of superficial dermatomycoses.Clin Ther. 1987;9(3):333-8. Clin Ther. 1987. PMID: 3300990 Clinical Trial.
-
Management of mycoses in daily practice.G Ital Dermatol Venereol. 2017 Dec;152(6):642-650. doi: 10.23736/S0392-0488.17.05683-8. G Ital Dermatol Venereol. 2017. PMID: 29050446 Review.
Cited by
-
Prevention and treatment of intertrigo in large skin folds of adults: a systematic review.BMC Nurs. 2010 Jul 13;9:12. doi: 10.1186/1472-6955-9-12. BMC Nurs. 2010. PMID: 20626853 Free PMC article.